Legend Biotech
LEGN
LEGN
195 hedge funds and large institutions have $1.9B invested in Legend Biotech in 2025 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 67 increasing their positions, 64 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 198 → 195 (-3)
11% less call options, than puts
Call options by funds: $13M | Put options by funds: $14.6M
30% less capital invested
Capital invested by funds: $2.73B → $1.9B (-$826M)
Holders
195
Holding in Top 10
6
Calls
$13M
Puts
$14.6M
Top Buyers
| 1 | +$85.1M | |
| 2 | +$79.9M | |
| 3 | +$79.8M | |
| 4 |
Goldman Sachs
New York
|
+$32.1M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$21.1M |
Top Sellers
| 1 | -$98.4M | |
| 2 | -$69.3M | |
| 3 | -$30M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$27.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$22.5M |
